No evidence of decreased artemisinin efficacy in a high-transmission malaria setting in Mali

Editorial

Caroline L Ng et al. Am J Trop Med Hyg. 2012 Jul.

. 2012 Jul;87(1):16-17.

doi: 10.4269/ajtmh.2012.12-0344.

No abstract available

Comment on

No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, Toure S, Sanogo K, Dama S, Sidibe B, Kone A, Thera MA, Plowe CV, Doumbo OK, Djimde AA. Maiga AW, et al. Am J Trop Med Hyg. 2012 Jul;87(1):23-8. doi: 10.4269/ajtmh.2012.12-0058. Am J Trop Med Hyg. 2012. PMID: 22764287 Free PMC article.

1. White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320:330–334. - PubMed
1. World Health Organization . Guidelines for the Treatment of Malaria. 2nd Ed. Geneva: World Health Organization; 2010.
1. Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7:864–874. - PMC - PubMed
1. Feachem R, Sabot O. A new global malaria eradication strategy. Lancet. 2008;371:1633–1635. - PubMed
1. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–2620. - PubMed